These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 16278384)
1. Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas. Feltmate CM; Lee KR; Johnson M; Schorge JO; Wong KK; Hao K; Welch WR; Bell DA; Berkowitz RS; Mok SC Clin Cancer Res; 2005 Nov; 11(21):7651-7. PubMed ID: 16278384 [TBL] [Abstract][Full Text] [Related]
2. Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women. Szych C; Staebler A; Connolly DC; Wu R; Cho KR; Ronnett BM Am J Pathol; 1999 Jun; 154(6):1849-55. PubMed ID: 10362811 [TBL] [Abstract][Full Text] [Related]
3. Genetic analysis of synchronous mucinous tumors of the ovary and appendix. Chuaqui RF; Zhuang Z; Emmert-Buck MR; Bryant BR; Nogales F; Tavassoli FA; Merino MJ Hum Pathol; 1996 Feb; 27(2):165-71. PubMed ID: 8617458 [TBL] [Abstract][Full Text] [Related]
4. Synchronous serrated adenoma of the appendix and high-grade ovarian carcinoma: a case demonstrating different origin of the two neoplasms. Rudzki Z; Zazula M; Białas M; Klimek M; Stachura J Pol J Pathol; 2002; 53(1):29-34. PubMed ID: 12014223 [TBL] [Abstract][Full Text] [Related]
5. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447 [TBL] [Abstract][Full Text] [Related]
6. A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas. Colitti CV; Rodabaugh KJ; Welch WR; Berkowitz RS; Mok SC Oncogene; 1998 Jan; 16(4):555-9. PubMed ID: 9484846 [TBL] [Abstract][Full Text] [Related]
7. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer. Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945 [TBL] [Abstract][Full Text] [Related]
8. Analysis of loss of heterozygosity for tumor-suppressor genes can accurately classify and predict the clinical behavior of mucinous tumors arising from the appendix. Maheshwari V; Tsung A; Lin Y; Zeh HJ; Finkelstein SD; Bartlett DL Ann Surg Oncol; 2006 Dec; 13(12):1610-6. PubMed ID: 17009159 [TBL] [Abstract][Full Text] [Related]
9. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas. Dodson MK; Hartmann LC; Cliby WA; DeLacey KA; Keeney GL; Ritland SR; Su JQ; Podratz KC; Jenkins RB Cancer Res; 1993 Oct; 53(19):4456-60. PubMed ID: 8402612 [TBL] [Abstract][Full Text] [Related]
10. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei. McKenney JK; Soslow RA; Longacre TA Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868 [TBL] [Abstract][Full Text] [Related]
11. Mucinous and nonmucinous appendiceal adenocarcinomas: different clinicopathological features but similar genetic alterations. Kabbani W; Houlihan PS; Luthra R; Hamilton SR; Rashid A Mod Pathol; 2002 Jun; 15(6):599-605. PubMed ID: 12065772 [TBL] [Abstract][Full Text] [Related]
12. Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers. Dion F; Mes-Masson AM; Seymour RJ; Provencher D; Tonin PN Oncogene; 2000 Mar; 19(11):1466-72. PubMed ID: 10723138 [TBL] [Abstract][Full Text] [Related]
13. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases. Vang R; Gown AM; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Ronnett BM Am J Surg Pathol; 2006 Sep; 30(9):1130-9. PubMed ID: 16931958 [TBL] [Abstract][Full Text] [Related]
14. Whole genome amplification and high-throughput allelotyping identified five distinct deletion regions on chromosomes 5 and 6 in microdissected early-stage ovarian tumors. Wang VW; Bell DA; Berkowitz RS; Mok SC Cancer Res; 2001 May; 61(10):4169-74. PubMed ID: 11358841 [TBL] [Abstract][Full Text] [Related]
16. Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene. Zenklusen JC; Weitzel JN; Ball HG; Conti CJ Oncogene; 1995 Jul; 11(2):359-63. PubMed ID: 7624150 [TBL] [Abstract][Full Text] [Related]
17. Expression of cytokeratin 7 in simultaneous mucinous tumors of the ovary and appendix. Guerrieri C; Frånlund B; Boeryd B Mod Pathol; 1995 Jun; 8(5):573-6. PubMed ID: 7545815 [TBL] [Abstract][Full Text] [Related]
18. Loss of SMAD4 protein expression is associated with high tumor grade and poor prognosis in disseminated appendiceal mucinous neoplasms. Davison JM; Hartman DA; Singhi AD; Choudry HA; Ahrendt SA; Zureikat AH; Ramalingam L; Nikiforova M; Pai RK Am J Surg Pathol; 2014 May; 38(5):583-92. PubMed ID: 24618609 [TBL] [Abstract][Full Text] [Related]
19. Genome-wide amplification and allelotyping of sporadic pituitary adenomas identify novel regions of genetic loss. Simpson DJ; Bicknell EJ; Buch HN; Cutty SJ; Clayton RN; Farrell WE Genes Chromosomes Cancer; 2003 Jul; 37(3):225-36. PubMed ID: 12759921 [TBL] [Abstract][Full Text] [Related]
20. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II. Young RH Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]